Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  SHENZHEN STOCK EXCHANGE  >  Jafron Biomedical Co.,Ltd.    300529   CNE100002995

JAFRON BIOMEDICAL CO.,LTD.

(300529)
  Report
End-of-day quote. End-of-day quote SHENZHEN STOCK EXCHANGE - 11/30
65.25 CNY   +2.51%
08/21JAFRON BIOMEDICAL CO.,LTD. : half-yearly earnings release
03/30JAFRON BIOMEDICAL CO.,LTD. : annual earnings release
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   End-of-day quote. End-of-day quote Shenzhen Stock Exchange
11/24/2020 11/25/2020 11/26/2020 11/27/2020 11/30/2020 Date
65.9 64.46 64.16 63.65 65.25 Last
3673445 7617959 2816832 4390933 5688319 Volume
-0.30% -2.19% -0.47% -0.79% +2.51% Change
Financials
Sales 2020 1 953 M 297 M 297 M
Net income 2020 802 M 122 M 122 M
Net Debt 2020 - - -
P/E ratio 2020 64,9x
Yield 2020 0,44%
Sales 2021 2 630 M 400 M 400 M
Net income 2021 1 074 M 164 M 164 M
Net Debt 2021 - - -
P/E ratio 2021 48,4x
Yield 2021 0,60%
Capitalization 52 142 M 7 928 M 7 937 M
Capi. / Sales 2020 26,7x
Capi. / Sales 2021 19,8x
Nbr of Employees 1 895
Free-Float 99,7%
More Financials
Company
Jafron Biomedical Co.,Ltd. is a China-based company principally engaged in the research, design, manufacture and distribute of biological materials and medical equipment. The Company’s products include disposable hemoperfusion devices, hemoperfusion machine, disposable bilirubin adsorbers, DX-10 blood purification machine, suture needle, as well as resins bandage, among others. The Company’s products are applied... 
More about the company
Notations Surperformance© of Jafron Biomedical Co.,Ltd.
Trading Rating : Investor Rating :
More Ratings
All news about JAFRON BIOMEDICAL CO.,LTD.
08/21JAFRON BIOMEDICAL CO.,LTD. : half-yearly earnings release
03/30JAFRON BIOMEDICAL CO.,LTD. : annual earnings release
More news
News in other languages on JAFRON BIOMEDICAL CO.,LTD.
08/21JAFRON BIOMEDICAL CO.,LTD. : Veröffentlichung des Halbjahresergebnisses
08/21JAFRON BIOMEDICAL CO.,LTD. : publication des résultats semestriels
03/30JAFRON BIOMEDICAL CO.,LTD. : publication des résultats annuels
03/30JAFRON BIOMEDICAL CO.,LTD. : Veröffentlichung des Jahresergebnisses
More news
Chart JAFRON BIOMEDICAL CO.,LTD.
Duration : Period :
Jafron Biomedical Co.,Ltd. Technical Analysis Chart | 300529 | CNE100002995 | MarketScreener
Technical analysis trends JAFRON BIOMEDICAL CO.,LTD.
Short TermMid-TermLong Term
TrendsBearishNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Average target price 95,66 CNY
Last Close Price 65,25 CNY
Spread / Highest target 46,6%
Spread / Average Target 46,6%
Spread / Lowest Target 46,6%
EPS Revisions
Managers
NameTitle
Fan Dong Chairman & General Manager
Xiao Hong Peng Chairman-Supervisory Board
Xiao Lian He Financial Director
Xian Min Tang Director & Deputy General Manager
Guang Hai Zhang Director & Deputy General Manager
Sector and Competitors
1st jan.Capitalization (M$)
JAFRON BIOMEDICAL CO.,LTD.72.57%7 928
ABBOTT LABORATORIES24.59%191 805
MEDTRONIC PLC0.22%152 480
BECTON, DICKINSON AND COMPANY-13.65%68 111
HOYA CORPORATION33.11%49 894
BAXTER INTERNATIONAL INC.-9.03%38 858